StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the medical device company’s stock.
Avinger Stock Up 2.1 %
NASDAQ AVGR opened at $0.97 on Tuesday. Avinger has a 52 week low of $0.90 and a 52 week high of $6.55. The firm has a market capitalization of $1.65 million, a price-to-earnings ratio of -0.05 and a beta of 1.17. The company has a fifty day moving average of $1.18 and a two-hundred day moving average of $2.20.
Avinger (NASDAQ:AVGR – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) EPS for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The company had revenue of $1.85 million for the quarter, compared to the consensus estimate of $2.55 million. Equities research analysts anticipate that Avinger will post -4.69 EPS for the current year.
Institutional Investors Weigh In On Avinger
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Further Reading
- Five stocks we like better than Avinger
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is the Euro STOXX 50 Index?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- When to Sell a Stock for Profit or Loss
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.